Ultivue Inc.
Cambridge, MA Part of Vizgen Inc.
- UEI
- ZE23LFTC5SV3
- CAGE
- 7FZ11
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Vizgen Inc.
Parent
KRW4BMDMFP39
- Ultivue Inc. ZE23LFTC5SV3
-
Vizgen Inc.
Parent
KRW4BMDMFP39
- SAM.gov registration date
- Physical address
- 763 Concord Ave, Cambridge, MA 02138, USA
- Website
- vizgen.com
- Founded
- 2019
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Software | National Cancer Institute | $15,000 | |
| Software | National Cancer Institute | $14,000 | |
| Biological kits | National Cancer Institute | $24,940 | |
| Proximity DNA exchange imaging | National Cancer Institute | $299,717 |
About Ultivue Inc.
Ultivue Inc. is a for-profit corporate entity registered in the System for Award Management (SAM.gov) since September 2015, with a registration valid through April 2025. Based on the available contract award information, the company appears to specialize in providing scientific and technological solutions primarily to federal research agencies, with a particular focus on biological and software-related products. While specific details about the company's full background are not provided, the contract awards suggest Ultivue Inc. operates in the life sciences and biotechnology sector, likely providing specialized research tools and software solutions to scientific institutions.
The company has secured multiple federal contract awards from the National Cancer Institute, a civilian agency under the Department of Health and Human Services (HHS) National Institutes of Health (NIH). These contracts, ranging from $14,000 to $24,940, have been predominantly purchase order-style agreements for specific scientific products. The contract awards demonstrate Ultivue Inc.'s capability to provide biological kits and software solutions, with recent awards focused on delivering specialized research materials. None of the contract awards utilized set-aside designations, indicating the company competes in open federal procurement processes. The contracts have consistent performance periods through mid-to-late 2024 and early 2025, with a geographic connection to Cambridge, Massachusetts, suggesting the company is likely based in or near this scientific and technological hub. The contract awards reveal a consistent pattern of supplying scientific research materials and software to federal research institutions, particularly within the cancer research domain.
Quick answers
What is Ultivue Inc.'s UEI?
Ultivue Inc.'s Unique Entity ID (UEI) in SAM.gov is ZE23LFTC5SV3.
What is Ultivue Inc.'s CAGE code?
Ultivue Inc.'s CAGE code is 7FZ11.
What is Ultivue Inc.'s primary NAICS code?
Ultivue Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Ultivue Inc. located?
Ultivue Inc.'s physical address in SAM.gov is 763 Concord Ave, Cambridge, MA 02138, USA.
Is Ultivue Inc. registered in SAM.gov?
Yes. Ultivue Inc.'s SAM.gov registration is active through June 10, 2027.
Who is Ultivue Inc.'s parent company?
Ultivue Inc. is part of Vizgen Inc.
What is Ultivue Inc.'s most recent federal award?
Ultivue Inc.'s most recent federal contract award is Software (75N91024P00730), from National Cancer Institute, on September 15, 2024.
On GovTribe
See Ultivue Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors